Published on
June 11, 2021
- 19:05 GMT
Master Insight Coach, John Strasser, Gives Thoughts on the New FDA Alzheimer's Drug Approved in Nearly 20 Years
LOS ANGELES, CA, UNITED STATES, June 11, 2021 /EINPresswire.com/ -- The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee …
Distribution channels:
Conferences & Trade Fairs, Culture, Society & Lifestyle
...
